{"transactions":[{"id":951064,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70289,"kind":"person","name":"Harvey Jimmie","position":1,"cik":"0001529687","reported_name":"Harvey Jimmie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common stock, par value $0.001","published_at":"2026-01-05T21:30:43.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":27322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 27,322 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2027, 2028, and 2029, subject to continued service.  The Reporting Person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions.  Vested deferred shares will be delivered to the Reporting Person on the January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total holdings include 143,365 shares underlying deferred restricted stock units."}],"balance_after":146704,"source":{"system":"sec-edgar","filing":"0001529687-26-000002","document":"form4-01052026_040117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000152968726000002/form4-01052026_040117.xml","form_type":"4"}},{"id":1314439,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70289,"kind":"person","name":"Harvey Jimmie","position":1,"cik":"0001529687","reported_name":"Harvey Jimmie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common stock, par value $0.001","published_at":"2025-01-03T21:20:11.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":49383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 49,383 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2026, 2027, and 2028, subject to continued service.  The reporting person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions.  Vested deferred shares will be delivered to the Reporting Person on the January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total holdings include 116,043 shares underlying deferred restricted stock units."}],"balance_after":119382,"source":{"system":"sec-edgar","filing":"0001415889-25-000427","document":"form4-01032025_040105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000141588925000427/form4-01032025_040105.xml","form_type":"4"}},{"id":1691992,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70289,"kind":"person","name":"Harvey Jimmie","position":1,"cik":"0001529687","reported_name":"Harvey Jimmie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2024-01-03T21:49:12.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":6666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the \"Reverse Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split."},{"field":"shares","element":"transactionShares","label":"F2","text":"One-third of the shares will vest on each of January 1, 2025, 2026, and 2027, subject to continued service. The reporting person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Total holdings include 66,660 shares underlying deferred restricted stock units."}],"balance_after":69999,"source":{"system":"sec-edgar","filing":"0001104659-24-000901","document":"tm241755-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465924000901/tm241755-4_4seq1.xml","form_type":"4"}},{"id":2067005,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70289,"kind":"person","name":"Harvey Jimmie","position":1,"cik":"0001529687","reported_name":"Harvey Jimmie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2023-01-05T02:23:26.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-third of the shares will vest on each of January1, 2024, 2025 and 2026, subject to continued service. The Reporting Person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the reporting person's termination of service, or earlier upon his death or change in control of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 900,000 shares of deferred restricted stock."}],"balance_after":950000,"source":{"system":"sec-edgar","filing":"0001104659-23-001094","document":"tm231728-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465923001094/tm231728-1_4seq1.xml","form_type":"4"}},{"id":2287831,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70289,"kind":"person","name":"Harvey Jimmie","position":1,"cik":"0001529687","reported_name":"Harvey Jimmie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2022-04-29T20:19:00.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-third of the shares will vest on each of January 1, 2023, 2024 and 2025, subject to continued service. The reporting person elected to defer 100% of these restricted shares pursuant to the issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the reporting person in January of the year following the reporting person's termination of service, or earlier upon his death or change in control of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 800,000 shares of deferred restricted stock."}],"balance_after":850000,"source":{"system":"sec-edgar","filing":"0001104659-22-053580","document":"tm2213913-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465922053580/tm2213913-4_4seq1.xml","form_type":"4"}},{"id":2752038,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70289,"kind":"person","name":"Harvey Jimmie","position":1,"cik":"0001529687","reported_name":"Harvey Jimmie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2021-04-09T21:21:35.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-third of the shares will vest on each of January 1, 2022, 2023 and 2024, subject to continued service. The reporting person elected to defer 100% of these restricted shares pursuant to the issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the reporting person in January of the year following the reporting person's termination of service, or earlier upon his death or change in control of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 700,000 shares of deferred restricted stock."}],"balance_after":750000,"source":{"system":"sec-edgar","filing":"0001104659-21-048821","document":"tm219139d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465921048821/tm219139d1_4.xml","form_type":"4"}},{"id":3210908,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70289,"kind":"person","name":"Harvey Jimmie","position":1,"cik":"0001529687","reported_name":"Harvey Jimmie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2020-03-13T20:06:15.000Z","date":"2020-01-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-third of the shares will vest on each January 1, 2021, 2022 and 2023, subject to continued service. The reporting person elected to defer 80% of these restricted shares pursuant to the issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the reporting person in January of the year following the reporting person's termination of service, or earlier upon his death or change in control of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 150,000 shares underlying deferred restricted stock units that were previously reported in Table II."}],"balance_after":650000,"source":{"system":"sec-edgar","filing":"0001104659-20-033108","document":"tm2011481-1_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465920033108/tm2011481-1_form4.xml","form_type":"4"}},{"id":3556565,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70289,"kind":"person","name":"Harvey Jimmie","position":1,"cik":"0001529687","reported_name":"Harvey Jimmie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2019-04-12T20:08:49.000Z","date":"2019-01-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-third of the shares will vest on each January 1, 2020, 2021 and 2022, subject to continued service. The reporting person elected to defer 100% of these restricted shares pursuant to the issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the reporting person in January of the year following the reporting person's termination of service, or earlier upon his death or change in control of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 150,000 shares underlying deferred restricted stock units that were previously reported in Table II."}],"balance_after":550000,"source":{"system":"sec-edgar","filing":"0001144204-19-019494","document":"tv516217_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000114420419019494/tv516217_4.xml","form_type":"4"}},{"id":3747536,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70289,"kind":"person","name":"Harvey Jimmie","position":1,"cik":"0001529687","reported_name":"Harvey Jimmie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-30T22:29:09.000Z","date":"2018-01-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-third of the shares will vest on each of January 1, 2019, 2020, and 2021, subject to continued service. The reporting person elected to defer these restricted shares pursuant to the issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred share units will be delivered to the reporting person in January of the year following the reporting person's termination of service, or earlier upon his death or a change in control."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 150,000 shares underlying deferred share units that were previously reported in Table II."}],"balance_after":450000,"source":{"system":"sec-edgar","filing":"0001144204-18-062680","document":"tv495937_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000114420418062680/tv495937_4.xml","form_type":"4"}},{"id":4253216,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70289,"kind":"person","name":"Harvey Jimmie","position":1,"cik":"0001529687","reported_name":"Harvey Jimmie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Units","published_at":"2017-07-21T20:08:57.000Z","date":"2017-03-10","kind":"grant","acquired":true,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Reporting Person was granted RSUs for service on the Strategic Transaction Committee in 2015, vesting one-third annually beginning on March 12, 2016. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Plan. Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the vesting of RSUs, the Reporting Person deferred the receipt of 16,666 shares of common stock and received instead 16,666 shares of deferred RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person was granted RSUs for service on the Strategic Transaction Committee in 2015, vesting one-third annually beginning on March 12, 2016. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Plan. Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Reporting Person was granted RSUs for service on the Strategic Transaction Committee in 2015, vesting one-third annually beginning on March 12, 2016. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Plan. Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan."}],"balance_after":49998,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001638599-17-000719","document":"doc4_4608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000163859917000719/doc4_4608.xml","form_type":"4"}},{"id":4253215,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70289,"kind":"person","name":"Harvey Jimmie","position":1,"cik":"0001529687","reported_name":"Harvey Jimmie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Units","published_at":"2017-07-21T20:08:57.000Z","date":"2017-03-10","kind":"grant","acquired":true,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") for service as a director in 2015, vesting one-third annually beginning on March 12, 2016. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Issuer's Deferred Compensation Plan for Directors (the \"Plan\"). Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set\nforth in the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the vesting of RSUs, the Reporting Person deferred the receipt of 16,666 shares of common stock and received instead 16,666 shares of deferred RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") for service as a director in 2015, vesting one-third annually beginning on March 12, 2016. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Issuer's Deferred Compensation Plan for Directors (the \"Plan\"). Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set\nforth in the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") for service as a director in 2015, vesting one-third annually beginning on March 12, 2016. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Issuer's Deferred Compensation Plan for Directors (the \"Plan\"). Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set\nforth in the Plan."}],"balance_after":49998,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001638599-17-000719","document":"doc4_4608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000163859917000719/doc4_4608.xml","form_type":"4"}},{"id":4482950,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70289,"kind":"person","name":"Harvey Jimmie","position":1,"cik":"0001529687","reported_name":"Harvey Jimmie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Units","published_at":"2017-01-24T23:54:39.000Z","date":"2017-01-01","kind":"grant","acquired":true,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Reporting Person was granted RSUs for service on the Strategic Transaction Committee in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Plan. Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the vesting of RSUs, the Reporting Person deferred the receipt of 16,666 shares of common stock and received instead 16,666 shares of deferred RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person was granted RSUs for service on the Strategic Transaction Committee in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Plan. Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Reporting Person was granted RSUs for service on the Strategic Transaction Committee in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Plan. Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan."}],"balance_after":33332,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001638599-17-000105","document":"doc4_4411.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000163859917000105/doc4_4411.xml","form_type":"4"}},{"id":4482949,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70289,"kind":"person","name":"Harvey Jimmie","position":1,"cik":"0001529687","reported_name":"Harvey Jimmie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Units","published_at":"2017-01-24T23:54:39.000Z","date":"2017-01-01","kind":"grant","acquired":true,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") for service as a director in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Issuer's Deferred Compensation Plan for Directors (the \"Plan\"). Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the vesting of RSUs, the Reporting Person deferred the receipt of 16,666 shares of common stock and received instead 16,666 shares of deferred RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") for service as a director in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Issuer's Deferred Compensation Plan for Directors (the \"Plan\"). Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") for service as a director in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Issuer's Deferred Compensation Plan for Directors (the \"Plan\"). Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan."}],"balance_after":33332,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001638599-17-000105","document":"doc4_4411.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000163859917000105/doc4_4411.xml","form_type":"4"}}]}